OM_OUT_1 [2025-03-20 12:39:15 -0400] 1984 Bytes | 573 tokens | Cum: 573 tkns (7.16% of 8k)
==========================================================================

You're the expert here today. So, I pulled together a bunch of data for you to look over real fast. I'm looking at high-performance stocks today and Outset Medical (OM) hit my radar screen, up to 10.38 from a prev close of 8.277 Do you think its got more juice or is it lacking potential? It's 12:39:13 PM on Thursday March 20, 2025 ET (UTC-0400) and I have to decide: buy or sell!

Here's the first list of news for Outset Medical:

C1 - Mar-18-25 08:30AM - Outset Medical Announces One-for-Fifteen Reverse Stock Split
C2 - Feb-26-25 09:55AM - Bears are Losing Control Over Outset Medical (OM), Here's Why It's a 'Buy' Now
C3 - Feb-24-25 04:03PM - Outset Medical to Present at the 45th Annual TD Cowen Health Care Conference
C4 - Feb-20-25 02:14PM - Q4 2024 Outset Medical Inc Earnings Call
C5 - Feb-20-25 02:14PM 02:13AM - Outset Medical Inc (OM) Q4 2024 Earnings Call Highlights: Revenue Growth and Strategic ...
C6 - Feb-19-25 05:15PM - Outset Medical, Inc. (OM) Reports Q4 Loss, Tops Revenue Estimates
C7 - Feb-19-25 05:15PM 04:03PM - Outset Medical Reports Fourth Quarter and Full Year 2024 Financial Results
C8 - Feb-19-25 05:15PM 05:00AM - Earnings To Watch: Outset Medical Inc (OM) Reports Q4 2024 Result

ONLY 3 RULES for AI:
==============
1) I am a document retrieval system. You are the analyst-investigator.
2) You can request items from my lists to get more info on Outset Medical (OM)
3) AFTER requesting and reading News and SEC filings you'll write a summary, set a score, high price target and headline.
Now, your response should be only 2 or 3 chars. You can say ex., C1, C2, etc., or NEX
The NEX command delivers the NEXt list of News/SEC/Metrics
There are several more lists that use our unified document retrieval system in subsequent prompts.
Your predictons will be compared to reality to rate your accuracy. Try to predict accurately. GOOD LUCK!
Please request a document, read, summarize and score. Say something like "C1".

OM_OUT_3 [2025-03-20 12:39:25 -0400] 967 Bytes | 236 tokens | Cum: 811 tkns (10.14% of 8k)
==========================================================================

Showing C5 (chunk 1 of 5): C5:
**Outset Medical Inc (OM) Q4 2024 Earnings Call Highlights: Revenue Growth and Strategic ...**
Date: Feb-20-25 02:14PM 02:13AM
Source: (GuruFocus.com)
URL: https://finance.yahoo.com/news/outset-medical-inc-om-q4-071340008.html

For the complete transcript of the earnings call, please refer to thefull earnings call transcript.

Outset Medical Inc (NASDAQ:OM) reported sequential revenue growth and a notable increase in gross margins for Q4 2024.

The company achieved a significant strengthening of its balance sheet with a $172.7 million equity financing, reducing outstanding debt from $200 million to $100 million.

Recurring revenue grew 13% sequentially and 17% year-over-year, driven by strong utilization across nearly 6,000 Tableau consoles.

The company received notification from the FDA that the warning letter from July 2023 had been officially closed, following a successful inspec

-- More? (MOR) or Next section? (NEX)

OM_OUT_5 [2025-03-20 12:39:37 -0400] 967 Bytes | 217 tokens | Cum: 1166 tkns (14.57% of 8k)
==========================================================================

Showing C5 (chunk 2 of 5): tion.

Outset Medical Inc (NASDAQ:OM) has a strong pipeline with 70% of top opportunities in late stages of the sales process, indicating potential for future growth.

Revenue for the full year 2024 was $113.7 million, below the original plan for the year.

Product revenue declined 8% year-over-year due to lower console sales.

The company is still facing challenges with under absorption of manufacturing overhead, affecting gross margins.

Operating expenses, although reduced, still amounted to $26.6 million for Q4 2024.

The company anticipates using under $50 million of cash in 2025, which, while reduced, still indicates significant cash outflow.

Warning! GuruFocus has detected 6 Warning Signs with OM.

Q: Can you provide more details on the console sales outlook and the confidence in achieving the projected growth despite a sequential decline in Q4 console revenues?A: Leslie Trigg, C

-- More? (MOR) or Next section? (NEX)

OM_OUT_7 [2025-03-20 12:39:39 -0400] 947 Bytes | 277 tokens | Cum: 1666 tkns (20.82% of 8k)
==========================================================================

We present this news so you can catch the big movers from recently breaking news.
Here's a list of news articles you can literally read just by asking.
Usually the first item is the most important.

A1 - 2025-03-18T17:27:00Z - Outset Medical Announces One-for-Fifteen Reverse Stock Split, Effective March 20, 2025...
A2 - 2025-03-18T13:36:57Z - Outset Medical stock hits 52-week low at $0.43 amid market challenges By Investing.com...
A3 - 2025-03-18T12:51:14Z - Outset Medical Announces One-for-Fifteen Reverse Stock Split...
A4 - 2025-02-24T21:19:04Z - Outset Medical to Present at the 45th Annual TD Cowen Health Care Conference - Outset Medical (NASDA...
A5 - 2025-02-24T21:28:20Z - Outset Medical to Present at the 45th Annual TD Cowen Health Care Conference...

Request an article by its reference number. (Ex., "A1" gets the first item)
You may also say NEX to go to the next listing.
Response to this prompt limited to 3 chars.

OM_OUT_9 [2025-03-20 12:39:46 -0400] 967 Bytes | 248 tokens | Cum: 1916 tkns (23.95% of 8k)
==========================================================================

Showing A1 (chunk 1 of 2): A1:
**Outset Medical Announces One-for-Fifteen Reverse Stock Split, Effective March 20, 2025**Date: 2025-03-18Source: {'uri': 'nasdaq.com', 'dataType': 'news', 'title': 'NASDAQ Stock Market'}URL: https://www.nasdaq.com/articles/outset-medical-announces-one-fifteen-reverse-stock-split-effective-march-20-2025(RTTNews) - Outset Medical, Inc. (OM) announced a one-for-fifteen reverse stock split of its common stock, effective March 20, 2025.

Trading will continue under the ticker OM on Nasdaq with a new CUSIP number. Approved by stockholders on March 5, 2025, the split consolidates every 15 pre-split shares into one, reducing outstanding shares from 265 million to approximately 17 million while maintaining the authorized share count and par value.

The split uniformly affects all stockholders, preserving ownership percentages except for fractional shares, which will be compensated in cash. E

-- More? (MOR) or Next section? (NEX)

OM_OUT_11 [2025-03-20 12:39:47 -0400] 997 Bytes | 307 tokens | Cum: 2369 tkns (29.61% of 8k)
==========================================================================

This is our final list of news.
News AI can literally read just by asking.
Don't miss the breaking news!

B1 - 2025-02-19T23:22:05Z - Outset Medical: Profitability Path Brightens
B2 - 2025-02-06T22:52:00Z - Kuehn Law Encourages Investors of Outset Medical, Inc. to Contact Law Firm
B3 - 2024-11-15T14:00:00Z - Outset Medical to Present at the 2024 Stifel Healthcare Conference
B4 - 2024-10-31T15:00:00Z - Outset Partners with User Interviews for Qualitative Research
B5 - 2024-10-23T23:51:00Z - Outset Medical, Inc. Investors: Please contact the Portnoy Law Firm to recover your losses. Oct. 28, 2024 Deadline to file Lead Plaintiff Motion
B6 - 2024-10-23T20:00:00Z - OM INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Outset Medical, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

Request an article by its reference number. (Ex., "B1" gets the first item)
You can say NEX to go to the next listing.
Response limited to 3 chars.

OM_OUT_13 [2025-03-20 12:39:56 -0400] 584 Bytes | 140 tokens | Cum: 2511 tkns (31.39% of 8k)
==========================================================================

Showing B1 (chunk 1 of 1): B1:
**Outset Medical: Profitability Path Brightens**Date: Unknown DateSource: Unknown SourceURL: https://www.fool.com/data-news/2025/02/19/outset-medical-profitability-path-brightens/?source=iedfolrf0000001Outset Medical reported strong Q4 earnings, with revenue and adjusted EPS beating analyst estimates. The company saw improved gross margins and reduced operating expenses, signaling progress towards profitability. Outset remains optimistic about future growth, projecting revenue of $115-$125 million by 2025.

-- More? (MOR) or Next section? (NEX)

OM_OUT_15 [2025-03-20 12:39:58 -0400] 1120 Bytes | 307 tokens | Cum: 2994 tkns (37.43% of 8k)
==========================================================================

This is our list of SEC filings.
Read it just by asking.
Don't miss breaking filings!

S6 - 2025-02-28 10-K Item 7. Mgts Discussion and Analysis of Fin Cond and Results of Oper.

The following discussion of our financial condition and results of operations is expected to better allow investors to view the Company from managements perspective and should be read...

S7 - 2025-02-26 8-K Item9.01 Fin Stmnts and Exhibits.

(d) Exhibits.

Exhibit

Number

Description

23.1 Consent of KPMG LLP. 31.1 Certification of Principal Exec Off pursuant to Rules 13a-14(a) and 15d-14(a) of the Securities Exchange Act of 1934, as amended (the Exchange Act),...

S8 - 2025-02-19 8-K Item 2.02 Result of Oper and Fin Cond.

On February 19, 2025, Outset Medial, Inc. (the Company) issued a press release announcing the Companys financial results for the quarter and year ended December 31, 2024, as well as a guidance for 2025 revenue and non-GAAP...

Request filing by its reference number. (Ex., "S1" gets the first item)
You can say NEX to go to the next listing - but what fun is that?
Response limited to 3 chars.

OM_OUT_17 [2025-03-20 12:40:02 -0400] 967 Bytes | 175 tokens | Cum: 3171 tkns (39.64% of 8k)
==========================================================================

Showing S6 (chunk 1 of 6): S6:
Item 7. Managements Discussion and Analysis of Financial Condition and Results of Operations.

The following discussion of our financial condition and results of operations is expected to better allow investors to view the Company from managements perspective and should be read together with our audited financial statements and related notes and other financial information included elsewhere in this Annual Report. The following discussion contains forward-looking statements that reflect our current plans, estimates and beliefs. Our actual results could differ materially from those discussed in the forward-looking statements as a result of various factors, including those discussed below and elsewhere in this Annual Report, particularly in the section titled Risk Factors. Our historical results are not necessarily indicative of the results that may be expected for any period in the f

-- More? (MOR) or Next section? (NEX)

OM_OUT_19 [2025-03-20 12:40:17 -0400] 6380 Bytes | 1889 tokens | Cum: 5063 tkns (63.29% of 8k)
==========================================================================

This is our set of metrics.
Please analyze the numbers.

+--------------------+-----------------------+-----------------------+-------------------------+------------------------+-----------------------+
| Volume: 208,295 | SMA50: -9.97% | Market Cap: 37.37M | Option/Short: Yes / Yes | Sales past 5Y: 69.86% | Sales Surprise: 3.59% |
+--------------------+-----------------------+-----------------------+-------------------------+------------------------+-----------------------+
| Avg Volume: 78.17K | SMA200: -53.77% | Shs Outstand: 3.53M | Short Float: 23.86% | Employees: 480 | EPS Surprise: 16.04% |
+--------------------+-----------------------+-----------------------+-------------------------+------------------------+-----------------------+
| Rel Volume: 5.62 | Perf Week: 25.26% | Shs Float: 3.14M | Short Ratio: 9.58 | Debt/Eq: 7.53 | P/E: - |
+--------------------+-----------------------+-----------------------+-------------------------+------------------------+-----------------------+
| RSI (14): 50.86 | Perf Month: -26.24% | Inst Own: 94.54% | Short Interest: 0.75M | Sales Y/Y TTM: -12.80% | Earnings: Feb 19 AMC |
+--------------------+-----------------------+-----------------------+-------------------------+------------------------+-----------------------+
| ATR (14): 1.48 | Perf Quarter: -34.59% | Insider Own: 12.68% | Beta: 2.06 | ROE: -170.97% | |
+--------------------+-----------------------+-----------------------+-------------------------+------------------------+-----------------------+
| SMA20: 5.16% | Index: - | Insider Trans: -4.42% | Sales Q/Q: -3.41% | ROI: -56.41% | |
+--------------------+-----------------------+-----------------------+-------------------------+------------------------+-----------------------+

The next section covers any insider trading.
If this section is blank, it's because there've been no recent filings.

Inside Trans: Outset Medical, Inc. (OM) by HACKETT PATRICK T (Unknown Title) on 2025-03-07
- Common Stock: 1250000 shares at $N/A (D)
- Common Stock: 1250000 shares at $N/A (I)
- Common Stock: 625000 shares at $N/A (I)
- Series A Non-Voting Convertible Preferred: 5000 shares at $200 (D)
- Series A Non-Voting Convertible Preferred: 5000 shares at $0 (D)
- Series A Non-Voting Convertible Preferred: 5000 shares at $200 (I)
- Series A Non-Voting Convertible Preferred: 5000 shares at $N/A (I)
- Series A Non-Voting Convertible Preferred: 2500 shares at $200 (I)
- Series A Non-Voting Convertible Preferred: 2500 shares at $0 (I)

Inside Trans: Outset Medical, Inc. (OM) by GROSSMAN D KEITH (Unknown Title) on 2025-03-07
- Common Stock: 187500 shares at $N/A (I)
- Series A Non-Voting Convertible Preferred: 750 shares at $200 (I)
- Series A Non-Voting Convertible Preferred: 750 shares at $0 (I)

Inside Trans: Outset Medical, Inc. (OM) by Drexler Karen (Unknown Title) on 2025-03-07
- Common Stock: 31250 shares at $N/A (I)
- Series A Non-Voting Convertible Preferred: 125 shares at $200 (I)
- Series A Non-Voting Convertible Preferred: 125 shares at $0 (I)

Inside Trans: Outset Medical, Inc. (OM) by LANG BRENT D. (Unknown Title) on 2025-03-07
- Common Stock: 250000 shares at $N/A (I)
- Series A Non-Voting Convertible Preferred: 1000 shares at $200 (I)
- Series A Non-Voting Convertible Preferred: 1000 shares at $0 (I)

Inside Trans: Outset Medical, Inc. (OM) by Trigg Leslie (Chair and CEO) on 2025-03-07
- Common Stock: 625000 shares at $N/A (I)
- Series A Non-Voting Convertible Preferred: 2500 shares at $200 (I)
- Series A Non-Voting Convertible Preferred: 2500 shares at $0 (I)

Inside Trans: Outset Medical, Inc. (OM) by Ahmed Nabeel (Chief Financial Officer) on 2025-02-18
- Common Stock: 8659 shares at $0.9 (D)

Inside Trans: Outset Medical, Inc. (OM) by Brottem John L. (General Counsel) on 2025-02-18
- Common Stock: 6145 shares at $0.9 (D)

[Company Financial Summary]
[Company Details]
Name: Outset Medical, Inc. Common Stock
Market Cap: N/A
Shares Outstanding: N/A
Sector: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS

[Financial Statements - Latest Quarter]
Total Assets: N/A
Total Liabilities: N/A
Total Equity: N/A
Revenue (Quarter): {'value': 113689000.0, 'unit': 'USD', 'label': 'Revenues', 'order': 100}
Net Income: {'value': -127976000.0, 'unit': 'USD', 'label': 'Net Income/Loss', 'order': 3200}
Earnings Per Share (EPS): N/A

[Price Metrics - Last 30 Days]
Latest Close: 10.375
Average Volume: 82697.09
30-Day High: 14.4
30-Day Low: 8.25

[Detailed Financials: TTM 2024]
- Total Assets: $275,795,000.0
- Total Liabilities: $248,976,000.0
- Total Equity: $26,819,000.0
- Current Assets: $258,221,000.0
- Current Liabilities: $45,378,000.0

[Income Statement: TTM 2024]
- Revenue: $113,689,000.0
- Net Income: $-127,976,000.0
- Operating Income: $-113,375,000.0
- Earnings Per Share (EPS): -2.46

[Cash Flow Statement: TTM 2024]
- Net Cash Flow: $55,505,000.0

[Detailed Financials: FY 2024]
- Total Assets: $275,795,000.0
- Total Liabilities: $248,976,000.0
- Total Equity: $26,819,000.0
- Current Assets: $258,221,000.0
- Current Liabilities: $45,378,000.0

[Income Statement: FY 2024]
- Revenue: $113,689,000.0
- Net Income: $-127,976,000.0
- Operating Income: $-113,375,000.0
- Earnings Per Share (EPS): -2.46

[Cash Flow Statement: FY 2024]
- Net Cash Flow: $55,505,000.0
==== END OF FINANCIAL REPORT ====

Now we've reached the end of the analysis.
You are now requested to make a summary analysis.
Please don't explain why you didn't have enough information.
Save that for the survey that comes last.

Finish the summary with two scores: MARKET_SCORE[] and PRICE_TARGET[]

If you calculate a 92% likelihood of an upward moves, say: MARKET_SCORE[92]
If you think the high today will be 50% higher, add to the price. Eg., If the price is $5.00, add 50%: PRICE_TARGET[$7.50]
PRICE_TARGET is the highest it is expected to rise today, so it cannot be less than the current price.
Please provide a thought-provoking take, 6-10 words, to use for the headline of this news story.
Like this: AI_RPT_HEADLINE: [6-10 words headline for news story from first summary paragraph]
1) Brief Summary, 2) MARKET_SCORE, 3) PRICE_TARGET, and 4) AI_RPT_HEADLINE

OM_OUT_21 [2025-03-20 12:40:23 -0400] 561 Bytes | 131 tokens | Cum: 5471 tkns (68.39% of 8k)
==========================================================================

Finally, if more data could have improved your confidence which would you have chosen? **Choose one option:**
-> X0 <- Nothing more would have helped my analysis
-> X1 <- More stock-specific news
-> X2 <- More SEC filings & insider data
-> X3 <- Broader sector & market news
-> X4 <- General market sentiment & AI confidence levels
-> X5 <- AI's past analysis on similar companies
-> X6 <- More financial metrics
-> X7 <- AI's past analysis on this exact company
-> X8 <- Something altogether different (explain...)

OM_IN_23 [2025-03-20 12:40:23 -0400] 126 Bytes | 29 tokens | Cum: 5600 tkns (70.00% of 8k)
==========================================================================

====================================
[2025-03-20 09:40:23] # Analysis Completed
Elapsed Time: 70.23 seconds